Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Docetaxel/ritonavir (Primary)
- Indications Advanced breast cancer; Bladder cancer; Cancer; Gastric cancer; Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Prostate cancer
- Focus Adverse reactions; Pharmacogenomic
- 23 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Dec 2010 Actual initiation date changed from Aug 2010 to Sep 2010 as reported by ClinicalTrials.gov.
- 17 Aug 2010 New trial record